solute carrier family 25 member 4
| GO Term | Evidence Code | PMID |
|---|---|---|
| liver development | ||
| heart development | ||
| apoptotic mitochondrial changes | ||
| apoptotic mitochondrial changes | ||
| negative regulation of cardiac muscle cell apoptotic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| mitochondrion | ||
| mitochondrial outer membrane | ||
| mitochondrial inner membrane | ||
| mitochondrial inner membrane | ||
| mitochondrial inner membrane |
| GO Term | Evidence Code | PMID |
|---|---|---|
| ATP:ADP antiporter activity | ||
| ATP:ADP antiporter activity | ||
| ATP:ADP antiporter activity | ||
| protein binding | ||
| proton transmembrane transporter activity |
| InterPro |
|---|
| ADP/ATP carrier protein, eukaryotic type |
| Mitochondrial carrier domain superfamily |
| Mitochondrial carrier protein |
| Mitochondrial substrate/solute carrier |
| Location | References |
|---|---|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026